Anomalous magnetic moment of the muon with dynamical QCD+QED von Westin, Alex, Kamleh, Waseem, Young, Ross, Zanotti, James, Horsley, Roger, Nakamura, Yoshifumi, Perlt, Holger, Rakow, Paul, Schierholz, Gerrit, Stüben, Hinnerk

Volltext

SlicerDMRI: Open Source Diffusion MRI Software for Brain Cancer Research von Norton, Isaiah, Essayed, Walid Ibn, Zhang, Fan, Pujol, Sonia, Yarmarkovich, Alex, Golby, Alexandra J, Kindlmann, Gordon, Wassermann, Demian, Estepar, Raul San Jose, Rathi, Yogesh, Pieper, Steve, Kikinis, Ron, Johnson, Hans J, Westin, Carl-Fredrik, O'Donnell, Lauren J

Volltext

Disrupted Axonal Fiber Connectivity in Schizophrenia von Zalesky, Andrew, Fornito, Alex, Seal, Marc L, Cocchi, Luca, Westin, Carl-Fredrik, Bullmore, Edward T, Egan, Gary F, Pantelis, Christos

Volltext

Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer von Kregel, Steven, Kiriluk, Kyle J, Rosen, Alex M, Cai, Yi, Reyes, Edwin E, Otto, Kristen B, Tom, Westin, Paner, Gladell P, Szmulewitz, Russell Z, Vander Griend, Donald J

Volltext

Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent: Final Results from a Phase II Study von Wagner, Patrick, Levine, Edward A., Kim, Alex C., Shen, Perry, Fleming, Nicole D., Westin, Shannon N., Berry, Laurel K., Karakousis, Giorgos C., Tanyi, Janos L., Olson, Madeline T., Madajewski, Brian, Ostrander, Brian, Krishnan, Kartik, Balch, Charles M., Bartlett, David L.

Volltext

ASO Visual Abstract: Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent—Final Results from a Phase 2 Stu... von Wagner, Patrick, Levine, Edward A., Kim, Alex C., Shen, Perry, Fleming, Nicole D., Westin, Shannon N., Berry, Laurel K., Karakousis, Giorgos C., Tanyi, Janos L., Olson, Madeline T., Madajewski, Brian, Ostrander, Brian, Krishnan, Kartik, Balch, Charles M., Bartlett, David L.

Volltext

A Six-Week Neuromuscular Training Program for Competitive Junior Tennis Players von Barber-Westin, Sue D, Hermeto, Alex A, Noyes, Frank R

Volltext

Promoting the use of the PI-QUAL score for prostate MRI quality: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship von Giganti, Francesco, Cole, Alexander P., Fennessy, Fiona M., Clinton, Timothy, Moreira, Pedro Lopes Da Frota, Bernardes, Mariana Costa, Westin, Carl-Fredrik, Krishnaswamy, Deepa, Fedorov, Andriy, Wollin, Daniel A., Langbein, Bjoern, Frego, Nicola, Labban, Muhieddine, Badaoui, Joy S., Chang, Steven L., Briggs, Logan G., Tokuda, Junichi, Ambrosi, Alessandro, Kirkham, Alex, Emberton, Mark, Kasivisvanathan, Veeru, Moore, Caroline M., Allen, Clare, Tempany, Clare M.

Volltext

Outcomes of patients with therapy‐related myeloid neoplasms after treatment with poly(ADP‐ribose) polymerase proteins inhibitors for solid tumours von Almanza‐Huante, Emmanuel, Bataller, Alex, Urrutia, Samuel, Gener‐Ricos, Georgina, Briski, Robert Edward, Kanagal‐Shamanna, Rashmi, Lu, Karen H., Westin, Shannon N., Yap, Timothy A., Takahashi, Koichi, Ravandi, Farhad, Alvarado, Yesid, Kadia, Tapan, Sasaki, Koiji, Kantarjian, Hagop M., Garcia‐Manero, Guillermo

Volltext

Fusion of white and gray matter geometry: A framework for investigating brain development von Savadjiev, Peter, Rathi, Yogesh, Bouix, Sylvain, Smith, Alex R., Schultz, Robert T., Verma, Ragini, Westin, Carl-Fredrik

Volltext

Detection of peritoneal metastases during cytoreductive surgery using pegsitacianine, a pH sensitive imaging agent: Final results from a phase 2 study von Wagner, Patrick, Levine, Edward Allen, Kim, Alex, Shen, Perry, Fleming, Nicole D., Westin, Shannon Neville, Berry, Laurel K, Karakousis, Giorgos Constantine, Tanyi, Janos Laszlo, Olson, Madeline, Ostrander, Brian, Krishnan, Kartik, Bartlett, David L.

Volltext

Outcomes of myeloid malignancies in patients previously treated with PARP inhibitors for solid malignancies: A single institution experience von Almanza-Huante, Emmanuel, Bataller, Alex, Urrutia, Samuel, Gener-Ricos, Georgina, Briski, Robert, Kanagal-Shamanna, Rashmi, Lu, Karen H., Westin, Shannon Neville, Yap, Timothy A., Takahashi, Koichi, Ravandi, Farhad, Alvarado Valero, Yesid, Kadia, Tapan M., Sasaki, Koji, Kantarjian, Hagop M., Garcia-Manero, Guillermo

Volltext

Influence of Sociodemographic Factors on Treatment Decisions in Non–Small-Cell Lung Cancer von Duma, Narjust, Idossa, Dame W., Durani, Urshila, Frank, Ryan D., Paludo, Jonas, Westin, Gustavo, Lou, Yanyan, Mansfield, Aaron S., Adjei, Alex A., Go, Ronald S., Ailawadhi, Sikander

Volltext

Abstract CT055: Phase 1/2 primary analysis of ZUMA-6: Axicabtagene ciloleucel (Axi-Cel) in combination With atezolizumab (Atezo) for the treatment of patients (Pts) with refractory... von Jacobson, Caron A., Westin, Jason R., Miklos, David B., Herrera, Alex F., Lee, Jennifer, Seng, Judy, Rossi, John M., Sun, Jennifer, Dong, Jinghui, Roberts, Zachary J., Vezan, Remus, Avanzi, Mauro P., Locke, Frederick L.

Volltext

ALPHA3: A Pivotal Phase 2 Study Evaluating the Safety and Efficacy of First-Line (1L) Consolidation With Cemacabtagene Ansegedleucel (Cema-Cel) in Patients With Large B-Cell Lympho... von Westin, Jason, Burke, John, Lynch, Ryan, Abramson, Jeremy, Stevens, Don, Matasar, Matthew, Fitzgerald, Lindsey, Zausner Skarbnik, Alan, Iragavarapu, Chaitanya, Essell, James, Hunter, Bradley, Merchant, Akil, Varadarajan, Indumathy, Tandra, Anand, Licitra, Edward, Bryan, Locke, Patel, Rushang D., Behl, Rajesh, Sharmann, Jeff, Holmes, Houston E., Fanning, Suzanne, Yimer, Habte, Gandhi, Mitul, Simmons, Gary, Feng, Amy, Navale, Lynn, Ghatta, Srinivas, Le Gall, John B., Herrera, Alex F.

Volltext

CT-412 ALPHA3: A Pivotal Phase 2 Study Evaluating the Safety and Efficacy of First-Line (1L) Consolidation With Cemacabtagene Ansegedleucel (Cema-Cel) in Patients With Large B-Cell... von Westin, Jason, Burke, John, Lynch, Ryan, Abramson, Jeremy, Stevens, Don, Matasar, Matthew, Fitzgerald, Lindsey, Zausner Skarbnik, Alan, Iragavarapu, Chaitanya, Essell, James, Hunter, Bradley, Merchant, Akil, Varadarajan, Indumathy, Rotte, Anand, Licitra, Edward, Bryan, Locke, Patel, Rushang D., Behl, Rajesh, Sharmann, Jeff, Holmes, Houston E., Fanning, Suzanne, Yimer, Habte, Gandhi, Mitul, Simmons, Gary, Feng, Amy, Navale, Lynn, Ghatta, Srinivas, Le Gall, John B., Herrera, Alex F.

Volltext

Abstract 4230: Influence of sociodemographic factors on treatment decisions in lung cancer von Duma, Narjust, Durani, Urshila, Frank, Ryan, Paludo, Jonas, Westin, Gustavo, Lou, Yanyan, Konstantinos, Leventakos, Molina, Julian, Go, Ronald, Mansfield, Aaron, Ailawadhi, Sikander, Adjei, Alex

Volltext

End of Phase 1 Results from Zuma-6: Axicabtagene Ciloleucel (Axi-Cel) in Combination with Atezolizumab for the Treatment of Patients with Refractory Diffuse Large B Cell Lymphoma von Jacobson, Caron A., Locke, Frederick L., Miklos, David B., Herrera, Alex F., Westin, Jason R., Lee, Jennifer, Rossi, John M., Zheng, Lianqing, Avanzi, Mauro P., Roberts, Zachary J., Sun, Jennifer

Volltext

Phase 1 Results from ZUMA-6: Axicabtagene Ciloleucel (axi-cel; KTE-C19) in Combination with Atezolizumab for the Treatment of Patients with Refractory Diffuse Large B Cell Lymphoma... von Locke, Frederick L., Westin, Jason R., Miklos, David B., Herrara, Alex F., Jacobson, Caron A., Lee, Jennifer, Rossi, John M., Bot, Adrian, Xue, Allen, Navale, Lynn, Aycock, Jeff S., Wiezorek, Jeffrey S., Roberts, Zachary J.

Volltext

Zuma-6: Phase 1-2 multicenter study evaluating safety and efficacy of axicabtagene ciloleucel (axi-cel; KTE-C19) in combination with atezolizumab in patients with refractory diffus... von Locke, Frederick Lundry, Westin, Jason R., Miklos, David Bernard, Herrera, Alex Francisco, Jacobson, Caron Alyce, Lee, Lillian, Rossi, John, Bot, Adrian, Xue, Allen, Navale, Lynn, Aycock, Jeff, Wiezorek, Jeffrey S., Roberts, Zachary

Volltext